This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Seattle Genetics, Inc., Pacific Northwest Research Institute, Fred Hutchinson Cancer Center. Active years: 2004-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 132 
2 out of 9 
1 out of 309 
Years Active: 2004-2016
Title: Nathalie Scholler: Innovator in Cancer Treatment
Introduction
Nathalie Scholler is a prominent inventor based in Seattle, WA, known for her significant contributions to cancer treatment. With a total of 9 patents, she has made remarkable strides in the field of oncology, particularly in the development of antibody-drug conjugates.
Latest Patents
Her latest patents include innovative treatments for renal cell carcinoma and B-cell cancers using anti-CD70 antibody-drug conjugates. These patents disclose anti-CD70 antibodies and their derivatives, which are conjugated to cytotoxic therapeutic agents. The pharmaceutical compositions and kits developed from these inventions are designed to treat CD70-expressing cancers effectively. The methods outlined in these patents involve administering the disclosed pharmaceutical compositions to subjects suffering from these types of cancer.
Career Highlights
Nathalie has worked with notable companies such as Seattle Genetics, Inc. and the Pacific Northwest Research Institute. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Alan F. Wahl and Linda Anne Pestano, who have played significant roles in her professional journey.
Conclusion
Nathalie Scholler's innovative work in cancer treatment through her patents showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic options for patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile